lobbying_activities: 3386671
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3386671 | ec003539-299f-4f43-94c7-42882baba0fb | Q2 | AMERICAN CLINICAL LABORATORY ASSN | 1923 | AMERICAN CLINICAL LABORATORY ASSN | 2025 | second_quarter | MED | Reimbursement and coverage issues for and related to clinical laboratory services, including the Medicare clinical laboratory fee schedule; laboratory test coding, pricing, coverage, and payment; implementation of the Protecting Access to Medicare Act (P.L. 113-93); diagnostic regulatory reform; artificial intelligence in laboratory services; utilization management, including prior authorization policies impacting clinical laboratories. | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE | 450000 | 0 | 0 | 2025-07-16T17:32:51-04:00 |